Cargando…

Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy

Histone deacetylase inhibitors (HDACi) have been approved and achieved success in hematologic malignancies. But its application in solid tumors still confronts big challenges and is hampered by low treatment efficacy. Nanotechnology has been widely applied in cancer therapy, and nanomedicine could i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Bin, Zhang, Meng, Liu, Tuanbing, Huang, Yongzhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284110/
https://www.ncbi.nlm.nih.gov/pubmed/32582697
http://dx.doi.org/10.3389/fcell.2020.00400

Ejemplares similares